RecruitingNot ApplicableNCT04932928

Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes Patients

Sponsor

Seoul National University Hospital

Enrollment

126 participants

Start Date

Mar 23, 2021

Study Type

INTERVENTIONAL

Conditions

Diabetes Mellitus, Type 2 Lifestyle Risk Reduction

Summary

We aim to provide medical nutritional therapy to patients with type 2 diabetes who are on oral hypoglycemic agents or on basal insulin only and monitor the glycemic response with flash glucose monitoring or self-monitoring of blood glucose. Specifically, this is a randomized, open-label, controlled study where half of the study participants will have FreeStyle Libre device on for 12 weeks and compare the change in glycated hemoglobin (HbA1c) value with the patients in the control group.

Eligibility

Min Age: 19 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether using a continuous glucose monitor (a small wearable sensor called FreeStyle Libre) helps people with type 2 diabetes make better lifestyle changes and improve their blood sugar control on their own. **You may be eligible if...** - You are between 19 and 80 years old - You have been diagnosed with type 2 diabetes - Your blood sugar is not well controlled (HbA1c between 7.0% and 10.0%) - You are willing and able to wear the glucose monitoring device **You may NOT be eligible if...** - You have type 1 diabetes or another form of diabetes - You use mealtime insulin injections - Your diabetes medications have changed in the last 3 months - You are pregnant or breastfeeding - You have severe liver or kidney disease - You take steroids or other medications that raise blood sugar Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.